Evidence map›Paper›PMID 24743021›Full record

ArticleBiochimica et biophysica acta2014

Two interdependent mechanisms of antimicrobial activity allow for efficient killing in nylon-3-based polymeric mimics of innate immunity peptides.

Michelle W Lee, Saswata Chakraborty, Nathan W Schmidt, Rajan Murgai, Samuel H Gellman, Gerard C L Wong

Open access · greenAbstract read
In one paragraph

Article in Biochimica et biophysica acta, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Direct Antimicrobial Activity of IFN-β.Journal of immunology (Baltimore, Md. : 1950) · 2017
    Article
  13. Article
  14. Helical antimicrobial polypeptides with radial amphiphilicity.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Michelle W LeeDepartment of Bioengineering, University of California, Los Angeles, CA 90095, United States.
Saswata ChakrabortyDepartment of Chemistry, University of Wisconsin, Madison, WI 53706, United States.
Nathan W SchmidtDepartment of Bioengineering, University of California, Los Angeles, CA 90095, United States.
Rajan MurgaiDepartment of Bioengineering, University of California, Los Angeles, CA 90095, United States.
Samuel H GellmanDepartment of Chemistry, University of Wisconsin, Madison, WI 53706, United States.
Gerard C L WongDepartment of Bioengineering, University of California, Los Angeles, CA 90095, United States; Department of Chemistry and Biochemistry, University of California, Los Angeles, CA 90095, United States; California NanoSystems Institute, University of California, Los Angeles, CA 90095, United States. Electronic address: gclwong@seas.ucla.edu.
University of California, Los Angeles · USUniversity of Wisconsin–Madison · USCalifornia NanoSystems Institute · US

Funding

Antimicrobial Oligomers for BioDefense and Emerging Food Borne Infectious DiseaseU01AI082192 · NIAID · UNIVERSITY OF MASSACHUSETTS AMHERST · PI TEW, GREGORY N. · 2009 to 2013
$7.0M
Design and Analysis of Random Copolymers with Antimicrobial ActivityR01GM093265 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI WEISSHAAR, JAMES C. · 2011 to 2018
$2.1M
NIAID NIH HHS 1U01 AI082192-01NIAID NIH HHS U01 AI082192NIGMS NIH HHS R01 GM093265
6 · The paper itself

Abstract

Novel synthetic mimics of antimicrobial peptides have been developed to exhibit structural properties and antimicrobial activity similar to those of natural antimicrobial peptides (AMPs) of the innate immune system. These molecules have a number of potential advantages over conventional antibiotics, including reduced bacterial resistance, cost-effective preparation, and customizable designs. In this study, we investigate a family of nylon-3 polymer-based antimicrobials. By combining vesicle dye leakage, bacterial permeation, and bactericidal assays with small-angle X-ray scattering (SAXS), we find that these polymers are capable of two interdependent mechanisms of action: permeation of bacterial membranes and binding to intracellular targets such as DNA, with the latter necessarily dependent on the former. We systemically examine polymer-induced membrane deformation modes across a range of lipid compositions that mimic both bacteria and mammalian cell membranes. The results show that the polymers' ability to generate negative Gaussian curvature (NGC), a topological requirement for membrane permeation and cellular entry, in model Escherichia coli membranes correlates with their ability to permeate membranes without complete membrane disruption and kill E. coli cells. Our findings suggest that these polymers operate with a concentration-dependent mechanism of action: at low concentrations permeation and DNA binding occur without membrane disruption, while at high concentrations complete disruption of the membrane occurs. This article is part of a Special Issue entitled: Interfacially Active Peptides and Proteins. Guest Editors: William C. Wimley and Kalina Hristova.

Indexed as

Antimicrobial Cationic PeptidesBacteriaBacterial InfectionsCell MembraneCell Membrane PermeabilityEscherichia coliHumansImmunity, InnateLipid BilayersNylonsPolymersAntimicrobial Cationic PeptidesLipid BilayersNylonsPolymersantimicrobial peptidesinnate immunitymembrane curvaturemembrane permeationpeptide–lipid interactionspore formation

Identifiers

PMID24743021
PMCPMC4405380
OpenAlexW2006197632

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.